Given the current situation, we understand that people may experience worry and even fear about how their disease and treatment may impact their personal risk. Sanofi Genzyme is committed to patient safety and to transparent communication. We are taking COVID-19 seriously, and we are committed to updating the communities we serve with relevant information related to our medicines to help inform health decisions.

As COVID-19 has emerged only recently, there are no available data regarding the impact of the virus on our current therapies. At this time, if you have general questions about our therapies, you should consult the current U.S Prescribing Information (USPI).

Each patient’s situation is unique, and patients and their healthcare providers are in the best position to make decisions regarding their care. In addition to local public health authority guidance, and local guidance from medical or patient associations, more information about COVID-19 can be found on the Centers for Disease Control’s (CDC) website or the World Health Organization’s (WHO) website.


For U.S. Residents Only

Here Are Some of the Dedicated Nurses
on the MS One to One® Team

MS One to One Nurses were chosen because of their:
  • Diverse nursing backgrounds, including MS experience
  • Passion to help and educate everyone affected by MS
  • Knowledge of treatment options for relapsing MS

But most of all, the Nurses of MS One to One are here because of their dedication and passion to help all people living with MS. They are committed to sharing knowledge and advice, as well as practical and emotional support.

MS One to One® Nurse, Claire

Nurse Claire
Helping since 2013

MS One to One® Nurse, Sharon

Nurse Sharon
Helping since 2013

MS One to One® Nurse, Carol

Nurse Carol
Helping since 2013

MS One to One® Nurse, Chantale

Nurse Chantale
Helping since 2013

Start your
conversation with
an MS One to One Nurse today.

Sign Up Now

Talk to a Nurse. Call 1‑855‑676‑6326.